Nexalin Technology (NXL) Operating Income (QoQ) (2021 - 2026)
Powered by 
Analysis
Nexalin Technology (NXL) Operating Income (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.01% |
| Mar 31, 2026 | 12.15% |
| Dec 31, 2025 | -2.88% |
| Sep 30, 2025 | -44.72% |
| Jun 30, 2025 | 19.41% |
| Mar 31, 2025 | 30.05% |
| Dec 31, 2024 | -14.63% |
| Sep 30, 2024 | -93.41% |
| Jun 30, 2024 | -20.80% |
| Mar 31, 2024 | 33.90% |
| Dec 31, 2023 | 32.75% |
| Sep 30, 2023 | -175.48% |
| Jun 30, 2023 | -12.50% |
| Mar 31, 2023 | -8.31% |
| Dec 31, 2022 | -145.44% |
| Sep 30, 2022 | 34.13% |
| Jun 30, 2022 | -18.66% |
| Mar 31, 2022 | 35.04% |
| Dec 31, 2021 | 67.84% |